The post MORPHO Technical Analysis Feb 3 appeared on BitcoinEthereumNews.com. MORPHO’s 24.14 million dollar trading volume over the last 24 hours confirms the priceThe post MORPHO Technical Analysis Feb 3 appeared on BitcoinEthereumNews.com. MORPHO’s 24.14 million dollar trading volume over the last 24 hours confirms the price

MORPHO Technical Analysis Feb 3

4 min read

MORPHO’s 24.14 million dollar trading volume over the last 24 hours confirms the price’s 8.91% rise with strong market participation; however, Bitcoin’s downtrend signals cautious volume accumulation in altcoins.

Volume Profile and Market Participation

MORPHO’s current volume profile stands out with 24.14 million dollars in trading volume over the last 24 hours. This level is about 150% above the 7-day average volume, indicating a significant increase in market participation. While the price records an 8.91% rise at the $1.28 level, the volume supporting this up-move is a sign of a healthy trend. According to volume profile analysis, the highest volume nodes (HVN) are concentrated in the $1.17-$1.24 range; this area has functioned as strong support in recent weeks and confirms that buyers are active here.

In terms of market participation, volume stays above average on up days, while it partially decreases on minor pullbacks. This indicates that both retail investors and big players are joining the rally. However, despite the overall uptrend, the Supertrend giving a bearish signal (resistance at $1.52) reveals that the volume profile thins out in the upper nodes ($1.35+). This situation emphasizes that participation has not yet reached peak levels and requires more volume confirmation. Comparatively, in altcoins under similar market conditions, volume increases exceeding 200% make momentum sustainable; MORPHO appears to be staying at 150% here.

Accumulation or Distribution?

Accumulation Signals

Accumulation signals are clear: volume spikes are observed at the $1.1778-$1.2380 support levels (scores 62-60/100). In these ranges, buyer volume increases before the price bottoms, forming a classic accumulation pattern. Staying above EMA20 ($1.22) and RSI at 55.48 in neutral territory support a quiet accumulation process. MTF volume levels (10 strong levels on 1D/3D/1W: 3S/3R balance) suggest institutional buyers are entering with a low profile. No volume divergence; volume rises as price rises, which is ideal for healthy accumulation.

Additionally, the bullish MACD histogram with volume confirmation forms a potential accumulation pool at the main support of $1.0480 (score 64/100). Big players may be accumulating positions here; as per the volume profile, low volume nodes (LVN) thin out at the top while bulking up at the bottom.

Distribution Risks

Distribution risks are low but present: volume increase at $1.2960 resistance (score 73/100) may signal selling pressure. If volume drops while breaking this level, there’s a fakeout risk. Supertrend bearish and BTC downtrend could trigger altcoin distribution. If volume dry-up is observed after recent high-volume upticks, it’s a distribution warning. Currently, risk is around 30%; watch the $1.3570-$1.4090 range.

Price-Volume Alignment

Price-volume alignment is strong: the 8.91% upmove is fully confirmed by volume. Volume increase on rises (up-volume/down-volume ratio 1.8:1) shows healthy momentum. No divergence; price staying above EMA20 is supported by the volume profile. However, if volume doesn’t peak while RSI is stable at 55.48, misalignment could form. For bullish target $1.9087 (score 25), volume needs to increase +20%; bearish $0.7502 (score 22) is triggered by volume collapse. Overall, volume confirms price action but remains cautious due to BTC influence.

Educational note: Healthy volume increases on upmoves and decreases on downmoves. This pattern holds for MORPHO; if unhealthy, volume would spike on downmoves.

Big Player Activity

Big player activities are evident from the wide HVNs in the volume profile: institutional footprints around $1.20. Whale wallet movements (per on-chain data) are net buyer-sided in the last 72 hours; 40% of the 24M volume from large blocks. Too early for distribution; on the contrary, accumulation footprints dominate at bottoms. Watch: if whale selling volume increases on $1.2960 test, it’s a reversal signal. Institutional pattern: Low volatility + high volume = stealth accumulation.

Bitcoin Correlation

Bitcoin at $78,342 +0.56% in downtrend (Supertrend bearish); supports at $77,638-$74,604. As an altcoin, MORPHO has 0.85% correlation to BTC; BTC decline could dry up alt volume. If BTC fails to break $79,303 resistance, fake rally risk increases in MORPHO. Key BTC levels: break below $77k pulls MORPHO to $1.17 support. Dominance rise crushes altcoin participation; caution mode now.

Volume-Based Outlook

Volume-based outlook is neutral with bullish bias: short-term accumulation continuation ($1.90 target), but BTC risk could test $1.05. If participation increases, uptrend becomes sustainable; if decreases, distribution begins. Recommendation: Follow MORPHO Spot Analysis for spot, MORPHO Futures Analysis for futures. The volume story reveals true strength beyond price.

This analysis uses Chief Analyst Devrim Cacal’s market views and methodology.

Senior Technical Analyst: James Mitchell

6 years of crypto market analysis

This analysis is not investment advice. Do your own research.

Source: https://en.coinotag.com/analysis/morpho-technical-analysis-february-3-2026-volume-and-accumulation

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge

Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge

The surge follows a difficult August, when investors pulled out more than $750 million while rotating capital into Ethereum-focused funds. […] The post Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge appeared first on Coindoo.
Share
Coindoo2025/09/18 01:15
CME Group to launch options on XRP and SOL futures

CME Group to launch options on XRP and SOL futures

The post CME Group to launch options on XRP and SOL futures appeared on BitcoinEthereumNews.com. CME Group will offer options based on the derivative markets on Solana (SOL) and XRP. The new markets will open on October 13, after regulatory approval.  CME Group will expand its crypto products with options on the futures markets of Solana (SOL) and XRP. The futures market will start on October 13, after regulatory review and approval.  The options will allow the trading of MicroSol, XRP, and MicroXRP futures, with expiry dates available every business day, monthly, and quarterly. The new products will be added to the existing BTC and ETH options markets. ‘The launch of these options contracts builds on the significant growth and increasing liquidity we have seen across our suite of Solana and XRP futures,’ said Giovanni Vicioso, CME Group Global Head of Cryptocurrency Products. The options contracts will have two main sizes, tracking the futures contracts. The new market will be suitable for sophisticated institutional traders, as well as active individual traders. The addition of options markets singles out XRP and SOL as liquid enough to offer the potential to bet on a market direction.  The options on futures arrive a few months after the launch of SOL futures. Both SOL and XRP had peak volumes in August, though XRP activity has slowed down in September. XRP and SOL options to tap both institutions and active traders Crypto options are one of the indicators of market attitudes, with XRP and SOL receiving a new way to gauge sentiment. The contracts will be supported by the Cumberland team.  ‘As one of the biggest liquidity providers in the ecosystem, the Cumberland team is excited to support CME Group’s continued expansion of crypto offerings,’ said Roman Makarov, Head of Cumberland Options Trading at DRW. ‘The launch of options on Solana and XRP futures is the latest example of the…
Share
BitcoinEthereumNews2025/09/18 00:56
The FDA Is Trying To Make Corporate Free Speech Situational

The FDA Is Trying To Make Corporate Free Speech Situational

The post The FDA Is Trying To Make Corporate Free Speech Situational appeared on BitcoinEthereumNews.com. BENSENVILLE, ILLINOIS – SEPTEMBER 10: Flanked by U.S. Attorney General Pam Bondi (rear), and FDA Commissioner Marty Makary (R), Secretary of Health and Human Services Robert F. Kennedy Jr. speaks to the press outside Midwest Distribution after it was raided by federal agents on September 10, 2025 in Bensenville, Illinois. According to the company, various e-liquids were seized in the raid. (Photo by Scott Olson/Getty Images) Getty Images While running for President in 2008, Barack Obama famously chanted “Yes we can.” Love or hate his political views, Obama’s politics were quite effective. He was asking voters to think big, to envision a much better future. Advertisers no doubt approved. That’s because ads routinely evoke things not as they are, but as they could be. Gyms and exercise equipment companies don’t promote their locations and equipment with flabby, lumbering people, rather their ads show fit, upright, energetic individuals. A look ahead. Restaurants do the same with ads showing happy people enjoying impressively put together plates of food. Conversely, ads meant to convince smokers to quit have not infrequently shown the worst of the worst future downsides of the habit. The nature of advertising comes to mind as FDA commissioner Marty Makary puzzlingly brags that “The Trump Administration Is Taking On Big Pharma” in the New York Times. Makary laments pharmaceutical ads that “are filled with dancing patients, glowing smiles and catch jingles that drown out the fine print.” Not explained is whether Makary would be happier if drug companies placed ads with immobile patients, frowns, and funereal music. Seriously, what does he expect? Does he want drug companies to commit billions to drug development to accompany their achievements with imagery defined by misery? Has Makary stopped to contemplate the myriad shareholders lawsuits drugmakers would face if, upon risking staggering sums meant…
Share
BitcoinEthereumNews2025/09/18 06:29